Seppo W. Langer
Seppo W. Langer
MD, PhD, Ass. Professor at Rigshospitalet, Copenhagen University Hospital
Bekræftet mail på regionh.dk
Titel
Citeret af
Citeret af
År
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study
H Sorbye, S Welin, SW Langer, LW Vestermark, N Holt, P Osterlund, ...
Annals of oncology 24 (1), 152-160, 2013
7302013
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies
HT Mouridsen, SW Langer, J Buter, H Eidtmann, G Rosti, M De Wit, ...
Annals of Oncology 18 (3), 546-550, 2007
2022007
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
BM Fischer, J Mortensen, SW Langer, A Loft, AK Berthelsen, BL Petersen, ...
Annals of Oncology 18 (2), 338-345, 2007
1712007
Treatment of anthracycline extravasation with dexrazoxane
SW Langer, M Sehested, PB Jensen
Clinical Cancer Research 6 (9), 3680-3686, 2000
1532000
Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study
M Quist, M Rørth, S Langer, LW Jones, JH Laursen, H Pappot, ...
Lung Cancer 75 (2), 203-208, 2012
1352012
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
ET Janson, H Sorbye, S Welin, B Federspiel, H Grønbæk, P Hellman, ...
Acta Oncologica 53 (10), 1284-1297, 2014
1232014
Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice
SW Langer, M Sehested, PB Jensen
Annals of oncology 12 (3), 405-410, 2001
892001
64Cu-DOTATATE PET for neuroendocrine tumors: a prospective head-to-head comparison with 111In-DTPA-octreotide in 112 patients
A Pfeifer, U Knigge, T Binderup, J Mortensen, P Oturai, A Loft, ...
Journal of Nuclear Medicine 56 (6), 847-854, 2015
872015
Head-to-head comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: a prospective study of 59 patients with neuroendocrine tumors
CB Johnbeck, U Knigge, A Loft, AK Berthelsen, J Mortensen, P Oturai, ...
Journal of Nuclear Medicine 58 (3), 451-457, 2017
822017
Neuroendocrine carcinomas of the gastroenteropancreatic system: a comprehensive review
EE Ilett, SW Langer, IH Olsen, B Federspiel, A Kjær, U Knigge
Diagnostics 5 (2), 119-176, 2015
822015
The impact of a multidimensional exercise intervention on physical and functional capacity, anxiety, and depression in patients with advanced-stage lung cancer undergoing …
M Quist, L Adamsen, M Rørth, JH Laursen, KB Christensen, SW Langer
Integrative cancer therapies 14 (4), 341-349, 2015
782015
Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone
SW Langer, AV Thougaard, M Sehested, PB Jensen
Cancer chemotherapy and pharmacology 57 (1), 125-128, 2006
732006
Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas
IH Olsen, JB Sørensen, B Federspiel, A Kjaer, CP Hansen, U Knigge, ...
The Scientific World Journal 2012, 2012
702012
Dexrazoxane for the treatment of chemotherapy-related side effects
SW Langer
Cancer Management and Research 6, 357, 2014
682014
Surgical treatment as a principle for patients with high-grade pancreatic neuroendocrine carcinoma: a Nordic multicenter comparative study
SP Haugvik, ET Janson, P Österlund, SW Langer, RS Falk, KJ Labori, ...
Annals of surgical oncology 23 (5), 1721-1728, 2016
652016
Dexrazoxane in anthracycline extravasation.
SW Langer, M Sehested, PB Jensen, J Buter, G Giaccone
Journal of clinical oncology: official journal of the American Society of …, 2000
622000
PET/CT imaging in response evaluation of patients with small cell lung cancer
BM Fischer, J Mortensen, SW Langer, A Loft, AK Berthelsen, G Daugaard, ...
Lung Cancer 54 (1), 41-49, 2006
572006
Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibition
LH Jensen, A Renodon-Corniere, I Wessel, SW Langer, B Søkilde, ...
Molecular pharmacology 61 (5), 1235-1243, 2002
542002
64Cu-DOTATATE for noninvasive assessment of atherosclerosis in large arteries and its correlation with risk factors: head-to-head comparison with 68Ga-DOTATOC in 60 patients
C Malmberg, RS Ripa, CB Johnbeck, U Knigge, SW Langer, J Mortensen, ...
Journal of Nuclear Medicine 56 (12), 1895-1900, 2015
532015
Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines
JN Jensen, J Lock-Andersen, SW Langer, J Mejer
Scandinavian journal of plastic and reconstructive surgery and hand surgery …, 2003
462003
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20